|
Hong Kong's advanced medical device market is backed by a top-tier healthcare system and skilled professionals. Its strategic location as a super-connector between China and the global market presents unique opportunities for the industry. By leveraging its proximity to China, foreign medical devices can access the Mainland, such as to the Greater Bay Area through initiatives like the "Medical Connect"*. Similarly, Chinese medical device companies can expand globally by taking advantage of Hong Kong’s path towards becoming a prime Innovation and Technology hub, which offers funding, R&D capabilities, and a conducive business environment.
|
|
|
|
|
Join our seminar to explore Hong Kong's pivotal role in the medical device industry, where you can gain insights on global market trends, the local ecosystem, and regulatory updates. Discover the opportunities available for medical device companies and stay informed about regulatory requirements for medical device registration in Hong Kong.
|
|
|
|
|
* The measure allows designated healthcare institutes operating in the Greater Bay Area to use Hong Kong registered drugs with urgent clinical use, and medical devices used in Hong Kong public hospitals with urgent clinical use, subject to the approval by Guangdong Province
|
|
|
|
|
9 September 2024 (Monday)
|
|
|
|
|
2:00pm Registration
2:30pm Presentations and Panel Discussions
5:30pm Networking Reception
|
|
|
|
|
JW Marriott Ballroom (Level 3)
|
|
|
|
|
English (with simultaneous interpretation in Putonghua and Japanese)
|
|
|
|
|
(Registrations are subject to acceptance on a “first-come-first-served” basis)
|
|
|
|
|
Welcome Remarks
|
|
|
|
Ms Alpha Lau
|
|
Director-General of Investment Promotion, Invest Hong Kong
|
|
|
|
|
Innovation in Medical Devices & Robotics - Edge of Hong Kong in Global Perspective
|
|
|
|
Prof Philip Chiu
|
|
Dean, Faculty of Medicine, The Chinese University of Hong Kong
|
|
|
Introduction of the Medical Device Administrative Control System (MDACS)
|
|
|
|
Ir Tommy Lam
|
|
Senior Electronics Engineers (Medical Device), Department of Health
|
|
|
|
|
China’s GBA Connect Scheme and NMPA Approval: Regulatory Essentials for MedTech
|
|
|
|
Mr Jacky Li
|
|
Senior Manager, Hong Kong & Taiwan, Cisema (Hong Kong) Limited
|
|
|
Certification and Quality Management Systems
|
|
|
|
Mr Don Lee
|
|
Senior Business Manager, Business Assurance, SGS United Kingdom Limited
|
|
|
|
|
MedTech Innovation from research to commercialisation
|
|
|
|
|
|
|
Ms Scarlett Chen
|
|
Managing Partner, Verge Health Tech Fund
|
|
|
|
|
Dr Grace Lau
|
|
Head of Institute for Translational Research, Hong Kong Science & Technology Parks Corporation
|
|
|
|
|
Prof Peng Shi
|
|
Department of Biomedical Engineering, City University of Hong Kong
|
|
|
|
|
|
|
Dr Kenneth Tsang
|
|
CEO, Gleneagles Hospital Hong Kong
|
|
|
|
|
Mr Andy Wong
|
|
Head of Innovation and Technology, Invest Hong Kong
|
|
Moderator
|
|
|
|
|
MedTech Opportunities in Hong Kong
|
|
|
|
|
|
|
Mr Dennis Guo
|
|
Managing Director, Joint Wise Innotech Limited
|
|
|
|
|
Dr Lydia Leung
|
|
Chairman, Hong Kong Medial and Healthcare Device Industries
|
|
|
|
|
Prof Christopher Schuhmacher
|
|
Director, Schuhmacher Consulting Limited
|
|
|
|
|
|
|
Mr Simon Yeung
|
|
COO, Time Medical
|
|
|
|
|
Ms Cathy Lui
|
|
Principal Manager (Biotech Enterprises), Invest Hong Kong
|
|
Moderator
|
|
|
|
|
Closing Remarks
|
|
|
|
Mr Andy Wong
|
|
Head of Innovation and Technology, Invest Hong Kong
|
|
|
|
|
Best Regards,
Invest Hong Kong
|
|
|
|
|
